BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20803552)

  • 21. Antithetic roles of proteoglycans in cancer.
    Garusi E; Rossi S; Perris R
    Cell Mol Life Sci; 2012 Feb; 69(4):553-79. PubMed ID: 21964924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
    Boissier P; Huynh-Do U
    Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
    Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
    FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of GEF-H1 induced signaling by heparanase in brain metastatic melanoma cells.
    Ridgway LD; Wetzel MD; Marchetti D
    J Cell Biochem; 2010 Dec; 111(5):1299-309. PubMed ID: 20803552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.
    Ridgway LD; Wetzel MD; Ngo JA; Erdreich-Epstein A; Marchetti D
    Mol Cancer Res; 2012 Jun; 10(6):689-702. PubMed ID: 22513363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparanase Modulates Shh and Wnt3a Signaling in Human Medulloblastoma Cells.
    Ridgway LD; Wetzel MD; Marchetti D
    Exp Ther Med; 2011 Mar; 2(2):229-238. PubMed ID: 21442027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.
    Liao YC; Ruan JW; Lua I; Li MH; Chen WL; Wang JR; Kao RH; Chen JH
    Oncogene; 2012 Jun; 31(25):3086-97. PubMed ID: 22002306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
    Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor-induced heparanase nucleolar localization augments DNA topoisomerase I activity in brain metastatic breast cancer.
    Zhang L; Sullivan P; Suyama J; Marchetti D
    Mol Cancer Res; 2010 Feb; 8(2):278-90. PubMed ID: 20164500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparanase: busy at the cell surface.
    Fux L; Ilan N; Sanderson RD; Vlodavsky I
    Trends Biochem Sci; 2009 Oct; 34(10):511-9. PubMed ID: 19733083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of collective cell migration at a glance.
    Ilina O; Friedl P
    J Cell Sci; 2009 Sep; 122(Pt 18):3203-8. PubMed ID: 19726629
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuronal Thy-1 induces astrocyte adhesion by engaging syndecan-4 in a cooperative interaction with alphavbeta3 integrin that activates PKCalpha and RhoA.
    Avalos AM; Valdivia AD; Muñoz N; Herrera-Molina R; Tapia JC; Lavandero S; Chiong M; Burridge K; Schneider P; Quest AF; Leyton L
    J Cell Sci; 2009 Oct; 122(Pt 19):3462-71. PubMed ID: 19723805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.
    O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT
    J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.